The largest analysis to date was performed by Couch et al. in a cohort of 28,536 BC patients, proposing BARD1 as a moderate-risk gene with an OR = 2.16 (CI = 1.31–3.63; p = 2.26 × 10−3) [9]. The gene discussed is BARD1; the disease is breast cancer.